Soper, J T <br/><br/>
Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.  [electronic resource] 

 -  Obstetrics and gynecology  Jan 1994 
 - 113-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0029-7844 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--administration & dosage<br/>Dactinomycin--administration & dosage<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Methotrexate--administration & dosage<br/>Pregnancy<br/>Prognosis<br/>Remission Induction<br/>Risk Factors<br/>Trophoblastic Neoplasms--drug therapy<br/>Uterine Neoplasms--drug therapy<br/>Vincristine--administration & dosage